JP2023519491A5 - - Google Patents
Info
- Publication number
- JP2023519491A5 JP2023519491A5 JP2022549886A JP2022549886A JP2023519491A5 JP 2023519491 A5 JP2023519491 A5 JP 2023519491A5 JP 2022549886 A JP2022549886 A JP 2022549886A JP 2022549886 A JP2022549886 A JP 2022549886A JP 2023519491 A5 JP2023519491 A5 JP 2023519491A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- inhibitor
- radiotherapy
- cxcl8
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20158787.0 | 2020-02-21 | ||
| EP20158787.0A EP3868369A1 (en) | 2020-02-21 | 2020-02-21 | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of cancer-related fatigue |
| PCT/EP2021/054231 WO2021165510A1 (en) | 2020-02-21 | 2021-02-19 | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of cancer-related fatigue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023519491A JP2023519491A (ja) | 2023-05-11 |
| JP2023519491A5 true JP2023519491A5 (https=) | 2023-12-07 |
Family
ID=69723868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549886A Pending JP2023519491A (ja) | 2020-02-21 | 2021-02-19 | 癌関連疲労の治療に使用するためのｃｘｃｌ８阻害剤およびその医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230090111A1 (https=) |
| EP (2) | EP3868369A1 (https=) |
| JP (1) | JP2023519491A (https=) |
| AU (1) | AU2021222360A1 (https=) |
| CA (1) | CA3166653A1 (https=) |
| IL (1) | IL294722A (https=) |
| WO (1) | WO2021165510A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1303249B1 (it) | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| PL1776336T3 (pl) | 2004-03-23 | 2010-06-30 | Dompe Farm Spa | Pochodne kwasu 2-fenylopropionowego i zawierające je kompozycje farmaceutyczne |
| EP2166006A1 (en) | 2008-09-18 | 2010-03-24 | Dompe' S.P.A. | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
-
2020
- 2020-02-21 EP EP20158787.0A patent/EP3868369A1/en not_active Withdrawn
-
2021
- 2021-02-19 AU AU2021222360A patent/AU2021222360A1/en not_active Abandoned
- 2021-02-19 US US17/800,634 patent/US20230090111A1/en not_active Abandoned
- 2021-02-19 WO PCT/EP2021/054231 patent/WO2021165510A1/en not_active Ceased
- 2021-02-19 EP EP21706579.6A patent/EP4106739A1/en not_active Withdrawn
- 2021-02-19 CA CA3166653A patent/CA3166653A1/en active Pending
- 2021-02-19 JP JP2022549886A patent/JP2023519491A/ja active Pending
-
2022
- 2022-07-12 IL IL294722A patent/IL294722A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12048682B2 (en) | Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy | |
| JP2023504286A5 (https=) | ||
| TW200418837A (en) | Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders | |
| CN103533940A (zh) | 治疗晚期实体瘤的方法 | |
| JP5642892B2 (ja) | 多形膠芽腫の治療のためのマシテンタンを含有する組み合わせ剤 | |
| CA3115068A1 (en) | Method for preparing and delivering bisantrene formulations | |
| JP2025163103A (ja) | 放射線および／または抗がん治療補助療法としてアデノシン二リン酸リボースの活用 | |
| JP4294957B2 (ja) | 金属錯体およびその治療的使用 | |
| JP2023519491A5 (https=) | ||
| US12377089B2 (en) | Quinoline derivative used for soft tissue sarcoma combination therapy | |
| CN1367690A (zh) | 使用五氟苯磺酰胺的综合疗法 | |
| US6822001B2 (en) | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents | |
| AU2009220942B2 (en) | Methods of treatment employing prolonged continuous infusion of Belinostat | |
| JP2010514743A (ja) | 白血病の治療のための新規な治療のための使用 | |
| JP2020528418A (ja) | ＢＥＴ阻害剤及びＢｃｌ−２阻害剤を用いた併用療法 | |
| TW200827361A (en) | Antitumor pharmaceutical composition | |
| JP2023514426A5 (https=) | ||
| CN103826645A (zh) | 砷在癌症治疗保护中的用途 | |
| CN116583289A (zh) | 癌症的新治疗方案 | |
| HK40067323A (en) | Quinoline derivative and epirubicin used for soft tissue sarcoma combination therapy | |
| CA3118053A1 (en) | Combination of chemotherapy with recombinant s. rolfsii lectin | |
| HK1152247B (en) | Methods of treatment employing prolonged continuous infusion of belinostat |